首页> 美国卫生研究院文献>other >Effect of Dual Antiplatelet Therapy on Shunt Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: A Matched Cohort Pilot Study
【2h】

Effect of Dual Antiplatelet Therapy on Shunt Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: A Matched Cohort Pilot Study

机译:双重抗血小板治疗对动脉瘤性蛛网膜下腔出血患者分流结局的影响:一项配对队列研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: The aim of this retrospective, matched cohort study is to determine the effect of dual antiplatelet therapy (DAPT) on shunt-related complications and long-term functional outcomes in endovascularly treated aneurysmal subarachnoid hemorrhage (aSAH) patients.Materials and Method: We retrospectively analyzed an institutional database of aSAH patients from 2000-2015. Patients who underwent endovascular treatment with stent-assisted coiling (DAPT cohort) were matched in a 1:4 ratio to those who underwent coiling alone (no-DAPT cohort) based on the presenting patient and aneurysm factors. A favorable outcome was defined as a modified Rankin scale of <2. Statistical analyses were performed to compare the shunt-related and functional outcomes between the DAPT and no-DAPT cohorts.Results: After applying the selection criteria and performing the matching process, the overall study cohort comprised 25 aSAH patients who underwent endovascular treatment, including five in the DAPT and 20 in the no-DAPT cohorts. The mean age, World Federation of Neurological Surgeons grade, aneurysm size, and follow-up duration of the overall study cohort were 52.3 years, 2.9, 7.4 mm, and 32.7 months, respectively. The mean time from aSAH to shunt placement was significantly higher for patients in the DAPT cohort (5.6 vs. 0.7 months; p=0.026). The shunt complication rates (p=0.562) and functional outcomes at last follow-up (p=0.924) were not significantly different between the two cohorts.Conclusion: Patients receiving DAPT after the stent-assisted coiling of acutely ruptured aneurysms do not have an increased risk of shunt-related complications or unfavorable long-term functional outcomes compared to endovascularly treated aSAH patients not taking DAPT. These results suggest that further study is warranted.
机译:目的:这项回顾性配对研究的目的是确定双重抗血小板治疗(DAPT)对血管内治疗的动脉瘤性蛛网膜下腔出血(aSAH)患者分流相关并发症和长期功能结局的影响。回顾性分析了2000年至2015年间aSAH患者的机构数据库。根据提出的患者和动脉瘤因素,以支架辅助卷绕(DAPT队列)进行血管内治疗的患者与单纯进行卷曲(无DAPT队列)的患者以1:4的比例相匹配。改良Rankin量表<2定义为良好结果。进行统计分析以比较DAPT和非DAPT队列之间的分流相关和功能结局。结果:在应用选择标准并执行匹配过程后,整个研究队列包括25例接受了腔内治疗的aSAH患者,其中包括5例在DAPT组中,有20个在非DAPT组中。整体研究队列的平均年龄,世界神经外科医师联合会等级,动脉瘤大小和随访时间分别为52.3岁,2.9、7.4 mm和32.7个月。对于DAPT队列中的患者,从aSAH到分流放置的平均时间明显更长(5.6 vs. 0.7个月; p = 0.026)。在这两个队列中,分流并发症发生率(p = 0.562)和最后一次随访的功能结局(p = 0.924)没有显着差异。结论:在支架辅助的急性破裂性动脉瘤卷绕后接受DAPT的患者没有与不接受DAPT的经血管内治疗的aSAH患者相比,与分流相关的并发症或长期功能不良的风险增加。这些结果表明需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号